Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 29.03.11 |
Sian Bigora
FOU | Founder | 63 | 29.03.11 |
David Young
FOU | Founder | 71 | 29.03.11 |
Patrick Lin
FOU | Founder | 58 | 29.03.11 |
George Ng
CEO | Chief Executive Officer | 49 | 08.08.23 |
Jim Stanker
DFI | Director of Finance/CFO | 67 | 05.09.18 |
Weifei Ye
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kayla Parks
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Mary Nyberg
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 08.08.23 |
James Neal
BRD | Director/Board Member | 68 | 16.07.22 |
Justin Yorke
CHM | Chairman | 58 | 02.10.17 |
Patrick Lin
FOU | Founder | 58 | 29.03.11 |
David Young
FOU | Founder | 71 | 29.03.11 |
Director/Board Member | 66 | 11.07.22 | |
Geraldine Pannu
BRD | Director/Board Member | 54 | 13.02.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 2 863 007 | 2 512 049 ( 87,74 %) | 5 000 ( 0,1746 %) | 87,74 % |
Unternehmenskontakt
Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive Suite 106
21076, Hanover
+
http://www.processapharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+40,73 % | 739 Mrd. | |
+32,83 % | 598 Mrd. | |
-6,30 % | 353 Mrd. | |
+15,15 % | 318 Mrd. | |
+4,05 % | 285 Mrd. | |
+15,00 % | 240 Mrd. | |
+9,78 % | 210 Mrd. | |
-5,52 % | 206 Mrd. | |
+6,17 % | 164 Mrd. |